The strategic investment function of the Fortis network, aimed at scaling clinical infrastructure.
About Fortis Healthcare Ventures
Fortis Healthcare Ventures is the strategic investment arm of Fortis Healthcare, one of India’s largest hospital networks, deploying $5M-$25M growth cheques aimed at scaling clinical infrastructure, including care delivery, tech-enabled services, and medical devices. The firm operates as a CVC with explicit strategic intent: portfolio companies often gain access to Fortis’s hospital network for clinical pilots, validation, and distribution. For founders, Fortis Ventures is best positioned as a strategic growth investor for mature health-tech, medical device, or tech-enabled service businesses that can credibly deploy across the Fortis network and ultimately scale to broader Indian and international hospital systems. The right founder profile is an Indian operator running a $10M+ revenue clinical infrastructure or medtech business with audited financials, regulatory clearances (CDSCO, FDA, CE), and a clear thesis on Fortis-network adoption as a deployment anchor. Pre-revenue founders, consumer wellness brands, asset-heavy hospital chains competing with Fortis, and pure software plays without clinical depth are a poor fit. The cleanest entry path is via the Fortis executive network, sell-side bankers with India healthcare practice depth, or warm introductions from existing portfolio CEOs. In the pitch, lead with clinical evidence, integration roadmap with hospital systems, multi-site deployment plans, and a credible international expansion narrative. Caveats: AI is not a stated focus, so AI-heavy founders should expect commercial rather than technical diligence and should bring external technical validators. Term sheets may include strategic terms tied to Fortis-network preferences, including rights of first refusal and distribution exclusivity worth negotiating carefully. Decision cadence is institutional and CVC mandates can shift with corporate priorities, so confirm pacing, vintage, and reserves explicitly during initial diligence.
Founder reviews
Other portfolio companies
Companies in Fortis Healthcare Ventures's portfolio not currently in our directory.
- Agilus Diagnostics
- eDreams
- eNext ICU · 2026
- RNT Health Insights · 2026
- Cartogene Therapeutics · 2026
- CarePal Money · 2026
- Tatvacare · 2026
- MicroHeal · 2026
- Nalagenetics · 2026
- Sunfox Technologies · 2026
- Kubo Care · 2026
- Cureous Labs · 2026
Team
Pitch / review this investor
Have you raised from Fortis Healthcare Ventures? Founders only — share your honest experience (anonymous OK, moderated before publishing).